首页> 外国专利> SET OF OLIGONUCLEOTIDES AND METHOD OF MULTIPLEX POLYMERASE CHAIN REACTION IN REAL TIME FOR DETECTION OF RNA SARS-COV-2

SET OF OLIGONUCLEOTIDES AND METHOD OF MULTIPLEX POLYMERASE CHAIN REACTION IN REAL TIME FOR DETECTION OF RNA SARS-COV-2

机译:用于检测RNA SARS-COV-2的实时寡核苷酸和多重聚合酶链反应的寡核苷酸和方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to the field of medicine and molecular biology, namely to the molecular genetic diagnosis of COVID-19 based on the detection of RNA of the SARS-CoV-2 coronavirus. The synthesized oligonucleotide primers and fluorescent probes are complementary exclusively to the nucleotide sequence (ORF1ab and N region) of the genome of the SARS-CoV-2 coronavirus and the human ABL1 gene. Also developed a method for detecting SARS-CoV-2 coronavirus RNA using multiplex RT-PCR based on amplification of ORF1ab and N regions of the SARS-CoV-2 coronavirus gene and human RNA ABL1 gene as an internal control.;EFFECT: invention allows reliably confirming the clinical diagnosis of COVID-19 with a minimum amount of the test material, 10 mcl, by monitoring the quality of sampling and RNA isolation by amplifying the RNA of the human ABL1 gene and determining the presence/absence of SARS-CoV-2 coronavirus RNA by amplification relative to control samples.;2 cl, 5 dwg, 6 tbl, 5 ex
机译:田地:药物。物质:发明涉及医学和分子生物学领域,即Covid-19的分子遗传诊断基于SARS-COV-2冠状病毒RNA的检测。合成的寡核苷酸引物和荧光探针专用于SARS-COV-2冠状病毒和人ABL1基因的基因组的核苷酸序列(ORF1ab和N区)。还开发了一种使用基于SARS-COV-2冠状病毒基因和人RNA ABL1基因的ORF1ab和N区的多重RT-PCR检测SARS-COV-2冠状病毒RNA的方法,作为内部对照。;效果:发明允许通过监测人ABL1基因的RNA和确定SARS-COV的存在/不存在,通过监测采样和RNA分离的最小量的测试材料,10MCL,可靠地确认Covid-19的临床诊断。 2冠状病毒RNA相对于对照样品进行扩增。; 2 cl,5 dwg,6 tbl,5例

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号